We altered NUB1 expression in HCC cells with or without treatment with the proteasome inhibitor MG132 (15 μM, 12 h), and western blotting showed that MG132 treatment abolished the change in PCNA expression mediated by the alteration of NUB1 expression (Fig. 3B). Here, PCNA is linked to hepatocellular carcinoma.